Most recently, it's been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in very similar regions as classical opioid receptors, it binds to the wide array of endogenous opioids. Compared with most opioid receptors, this receptor functions as a scavenger https://georgesc913ezr0.blogcudinti.com/profile